1Rapoport AM, Bigal ME, Tepper S, et al. Intranasal medications for the treatment of migraine and cluster headache [J]. CNS DRUG, 2004,18(10) :671-685
2Bigal,ME, Lipton RB. Krymchantowsk Abouch V. The medical management of migraine [ J ]. American Journal of Therapeutics, 2004,11(2) :130-140
3Silberstein S, Tepper S, Brandes J. Randomizes, placebocontrolled trial of rofecoxib in the acute treatment of migraine [J]. Neurology, 2004,62:1552-1557
4Fanciullacci, M. Seeking the best care for acute migraine [ J ]. J Headache Pain, 2002,3:1-5
5Ghose K, Niven BE, Berry D. A double-blind crossover comparison of the effects of vigabatrin with placebo in the prevention of migraine headache [ J ]. J Headache Pain,2002,3:79-85
6Ashkenazi A, Silberstein, Stephen D. The evolving management of migraine[J]. Neurology, 2003,16(3) :341-345
7Syrett N, Abu-Shakra S, Yates R. D Zolmitriptan nasal spray: advance in migraine treatment [ J ]. Neurology . 2003,61 ( Suppl 4): S27-S30
8Steiner TJ, Diener HC, MacGregor EA, et al. Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine[ J ]. Cephalalgia,2003,23:942-952
9Dodick D, Lipton RB, Martin V. Concensus statement: Cardiovacular safety profile of triptans(5-HT1B/1D agonist )in the acute treatment of migraine[J]. Headache, 2004,44: 414-425
10Edvinsson L, Krlause DN, eds. Cerebral bloodflow and metabolism[ M]. 2nd ed. Philadelphia: Lippincott Williams & Wilkins, 2002
